Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Equity

v3.22.1
Equity
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Equity

Note 11. Equity

a. Stock-based compensation plans

Stock-based compensation expenses for equity-classified stock options, restricted share units (“RSUs”) and performance-based restricted share units (PSUs) were allocated as follows:

 

    Three Months Ended March 31,
    2022   2021
    U.S $ in thousands
         
Cost of sales   $ 900     $ 634  
Research and development, net     1,786       1,424  
Selling, general and administrative     5,847       5,147  
Total stock-based compensation expenses   $ 8,533     $ 7,205  

A summary of the Company’s stock option activity for the three months ended March 31, 2022 is as follows:

 

    Number of Options Weighted Average Exercise Price
Options outstanding as of January 1, 2022   $ 1,732,368   $ 28.85  
Granted    
-
   
-
 
Exercised     (12,829   12.02  
Forfeited     (13,605   25.11  
Options outstanding as of March 31, 2022     1,705,934     29.01  
Options exercisable as of March 31, 2022   $ 1,374,696   $ 32.04  

As of March 31, 2022, the unrecognized compensation cost of $2.1 million related to all unvested, equity-classified stock options is expected to be recognized as an expense over a weighted-average period of 2.7 years.

 

A summary of the Company’s RSUs and PSUs activity for the three months ended March 31, 2022 is as follows:

 

    Number of RSUs and PSUs Weighted Average Grant Date Fair Value
Unvested as of January 1, 2022   $ 3,082,798   $ 26.36  
Granted     1,377,792     22.13  
Vested     (721,316   27.30  
Forfeited     (68,830   26.87  
Unvested as of March 31, 2022   $ 3,670,444   $ 24.58  

The fair value of RSUs and PSUs is determined based on the quoted price of the Company’s ordinary shares on the date of the grant.

As of March 31, 2022, the unrecognized compensation cost of $75 million related to all unvested, equity-classified RSUs and PSUs is expected to be recognized as expense over a weighted-average period of 2.7 years.

 

b. Accumulated other comprehensive loss

The following tables present the changes in the components of accumulated other comprehensive income (loss), net of taxes, for the three months ended March 31, 2022 and 2021, respectively:

 

    Three Months Ended March 31, 2022
    Net Unrealized Gain (Loss) on Cash Flow Hedges     Foreign Currency Translation Adjustments     Total
    U.S. $ in thousands
                 
Balance as of January 1, 2022   $ 1,572       $ (10,343     $ (8,771
Other comprehensive income (loss) before reclassifications     271         (702       (431
Amounts reclassified from accumulated other comprehensive loss     (622      
-
        (622
Other comprehensive income (loss)     (351       (702       (1,053
Balance as of March 31, 2022   $ 1,221       $ (11,045     $ (9,824
    Three Months Ended March 31, 2021
    Net Unrealized Gain (Loss) on Cash Flow Hedges     Foreign Currency Translation Adjustments     Total
    U.S. $ in thousands
                 
Balance as of January 1, 2021   $ (1,673     $ (7,173     $ (8,846
Other comprehensive income (loss) before reclassifications     1,607         (961       646  
Amounts reclassified from accumulated other comprehensive loss     566        
-
        566  
Other comprehensive income (loss)     2,173         (961       1,212  
Balance as of March 31, 2021   $ 500       $ (8,134     $ (7,634

c. Public offering of ordinary shares

During March 2021, the Company completed a capital raise of $218.9 million, net of underwriting discounts and offering expenses. The total number of shares sold by the Company in the public offering was 7,931,034.
 
       A deferred tax asset in an amount of $1.2 million was recorded in respect of a tax benefit, arising from the underwriting discounts and offering expenses, as an increase to Additional Paid-In Capital.